Nuvectis Pharma, Inc. NVCT Accrued Liabilities, Current
Accrued Liabilities, Current at other companies
Other financials
Where this comes from
Reported directly by Nuvectis Pharma, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccruedLiabilitiesCurrent.
The official record: Nuvectis Pharma, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Nuvectis Pharma, Inc.'s accrued liabilities, current.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Nuvectis Pharma, Inc.'s accrued liabilities, current?
- Nuvectis Pharma, Inc. (NVCT) reported accrued liabilities, current of $36K in Q1 2026.
- How has Nuvectis Pharma, Inc.'s accrued liabilities, current changed year-over-year?
- Nuvectis Pharma, Inc.'s accrued liabilities, current decreased by 95.8% year-over-year, from $865K to $36K.
- What is the long-term trend for Nuvectis Pharma, Inc.'s accrued liabilities, current?
- Over 4 years (2021 to 2025), Nuvectis Pharma, Inc.'s accrued liabilities, current has grown at a -26.5% compound annual growth rate (CAGR), from $395K to $115K.